|
⚲
|
| Keyboard |
| Sabus Steve M
✚
|
|
|---|---|
| CIK # | 0001930884 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001930884] | |
| 4 | [0001930884] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sabus Steve M | |
| Syndax Pharmaceuticals Inc | |
| Turning Point Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Syndax Pharmaceuticals Inc SNDX
Stock Options (Right to buy) · derivative
|
2022-12-05 | Grant | 220,000 | $25.44 | 5,596,800 |
|
Turning Point Therapeutics Inc TPTX
Common Stock
|
2022-08-17 | Disposed to issuer | 36,667 | $76.00 | 2,786,692 |
|
Turning Point Therapeutics Inc TPTX
Stock Option (right to buy) · derivative
|
2022-08-17 | Disposed to issuer | 165,000 | ||
|
Turning Point Therapeutics Inc TPTX
Common Stock
|
2022-05-31 | Grant | 36,667 | $0.00 | |
|
Turning Point Therapeutics Inc TPTX
Stock Option (right to buy) · derivative
|
2022-05-31 | Grant | 165,000 | $0.00 |